G protein-coupled receptors: a gateway to targeting oncogenic EVs?
2024

G protein-coupled receptors: a gateway to targeting oncogenic EVs?

publication Evidence: moderate

Author Information

Author(s): Di Niro Lotte, Linders Amber C., Glynn Thomas, Pegtel D. Michiel, Siderius Marco, Crudden Caitrin, Smit Martine J.

Primary Institution: Vrije Universiteit Amsterdam

Hypothesis

Can G protein-coupled receptors (GPCRs) be targeted to modulate oncogenic extracellular vesicles (EVs) in cancer therapy?

Conclusion

GPCRs may serve as potential therapeutic targets for modulating cancer-associated EVs and improving treatment strategies.

Supporting Evidence

  • GPCRs are involved in the regulation of EV biogenesis and secretion.
  • Targeting GPCRs may enhance the effectiveness of cancer therapies by modulating EV-mediated communication.
  • Studies have shown that GPCRs can influence the cargo of EVs, affecting tumor progression.

Takeaway

This study looks at how certain proteins called GPCRs can help us understand and potentially control tiny bubbles called EVs that cancer cells use to communicate and grow.

Methodology

The review examines existing literature on the role of GPCRs in EV biology and their implications in cancer progression.

Potential Biases

Potential bias may arise from the selective reporting of studies that support the hypothesis while overlooking contradictory evidence.

Limitations

The review does not provide new experimental data and relies on existing studies, which may have varying methodologies and results.

Digital Object Identifier (DOI)

10.20517/evcna.2024.10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication